Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;3(11):e935.
doi: 10.1002/cpz1.935.

Canine Models of Inflammatory Skin Diseases and Their Application in Pharmacological Research

Natalia Gil  1 , Domenico Santoro  1
Affiliations
Review

Canine Models of Inflammatory Skin Diseases and Their Application in Pharmacological Research

Natalia Gil et al. Curr Protoc. 2023 Nov.

Abstract

The purpose of this article is to provide an overview of existing pharmacological models of canine dermatitis. Canine models of dermatitis have contributed significantly to our current understanding of the pathology of dermatitis and to the development of corresponding pharmacological interventions. Specifically, canine atopic dermatitis (AD) is reviewed here, as it is one of the most common inflammatory skin diseases in dogs. Canine AD also shares clinicopathological features with human AD, making the dog a natural and optimal model for human disease. Thus, pharmacological models of canine AD may be uniquely applicable to human pharmacological research. In this article, particular attention is dedicated to relevant in vivo, in vitro, and ex vivo models of canine AD, skin barrier defect models, pruritus models, and skin immunology models. Additionally, models of superficial pyoderma and food allergy are also discussed. With understanding of findings from canine models, researchers can select the most salient features for future pharmacological drug development. © 2023 Wiley Periodicals LLC.

Keywords: allergies; canine models; ex vivo; in vitro; in vivo; inflammatory skin diseases.

PubMed Disclaimer

References

LITERATURE CITED

    1. Asahina, R., Ueda, K., Oshima, Y., Kanei, T., Kato, M., Furue, M., Tsukui, T., Nagata, M., & Maeda, S. (2020). Serum canine thymus and activation-regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis. Veterinary Dermatology, 31(6), 446-455. https://doi.org/10.1111/vde.12894
    1. Bae, S., Kim, K., & Oh, T. (2018). The effect of an ex vivo boosted immune cell therapy on canine atopic dermatitis: An open, uncontrolled pilot study. Veterinary Dermatology, 29(6), 504-e169. https://doi.org/10.1111/vde.12687
    1. Bauman, A. B., Moeller, C. E., Soileau, A. M., Goodermuth, C. E., Costa, V. R., Schaumburg, J. C., Pucheu- Haston, C. M., Welborn, N. D., Dehghanpir, S. D., Mitchell, M. A., & Withers, S. S. (2022). Canine memory T-cell subsets in health and disease. Veterinary Immunology and Immunopathology, 246, 110401. https://doi.org/10.1016/j.vetimm.2022.110401
    1. Bäumer, W., Bizikova, P., Jacob, M., & Linder, K. E. (2017). Establishing a canine superficial pyoderma model. Journal of Applied Microbiology, 122(2), 331-337. https://doi.org/10.1111/jam.13362
    1. Bruet, V., Lieubeau, B., Herve, J., Roussel, A., Imparato, L., Desfontis, J. C., & Bourdeau, P. (2015). Increased numbers of peripheral blood CD34+ cells in dogs with canine atopic dermatitis. Veterinary Dermatology, 26(3), 160-e33. https://doi.org/10.1111/vde.12191

LinkOut - more resources